Biotech
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/22/16 -- Hemostemix Inc. ("Hemostemix" or the "Company") (TSX VENTURE: HEM) (OTCQB: HMTXF) today announces a non-brokered private placemen ...
RALEIGH-DURHAM, NC: Prestigious Conference Presented by the Center for Dermal Research at Rutgers University ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/21/16 -- Hemostemix Inc. ("Hemostemix" or the "Company) (TSX VENTURE: HEM)(OTCQX: HMTXF), a clinical-stage autologous cell-therapy company, ann ...
EDMONTON, ALBERTA: Ceapro Enters into a multi-partners' project through Alberta-Germany Collaboration Fund for Product Development and Commercialization of PGX Technology ...
CAMBRIDGE, MASSACHUSETTS: CAMBRIDGE, MASSACHUSETTS -- (Marketwired) -- 09/20/16 -- VBI Vaccines Inc. (NASDAQ: VBIV)(TSX: VBV) ("VBI") today announced that it has completed enrollment and initial dosing of all partic ...
HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 09/20/16 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical-stage vaccine and immunotherapy com ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/19/16 -- Flamel Technologies (NASDAQ: FLML) today announced that management will present at the Ladenburg Thalmann 2016 Healthcare Conference. Michael Anderson, Ch ...
TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 09/19/16 -- Aphria Inc. ("Aphria") (TSX VENTURE: APH)(OTCQB: APHQF), in connection with its previously announced licensing deal with Tokyo Smoke, a pre ...
SYDNEY, AUSTRALIA: New Molecular Assay Is Only Commercial Test to Detect Both M. genitalium and Antibiotic Resistance for One of the World's Fastest Spreading Sexually Transmitted Diseases ...
LYON, FRANCE: LYON, FRANCE -- (Marketwired) -- 09/19/16 -- Flamel Technologies (NASDAQ: FLML) today announced it will host a meeting for investors and analysts on Monday, September 26, 2016. The event will take pl ...
LOS ALTOS, CA: First-in-Human Trial Achieves Safety, Tolerability, and PK Goals, With Early Signals of Efficacy ...
SANTA ANA, CA: SANTA ANA, CA -- (Marketwired) -- 09/16/16 -- Io Therapeutics, Inc., today, reported data demonstrating that the company's experimental rexinoid nuclear receptor (RXR) agonist compound, IRX4204, ...
LONDON, UNITED KINGDOM: LONDON, UNITED KINGDOM -- (Marketwired) -- 09/15/16 -- Tiziana Life Sciences plc (AIM: TILS)("Tiziana" or the "Company")London, 15 September 2016 - Tiziana Life Sciences plc (AIM: ...
LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 09/14/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehyde ...
LAS VEGAS, NEVADA: LAS VEGAS, NEVADA -- (Marketwired) -- 09/13/16 -- Online Disruptive Technologies, Inc. (OTC PINK: ONDR) (the "Company") is pleased to announce that its majority owned Israeli subsidiary, S ...
PALO ALTO, CA: New Software Startup Experiences Enormous Worldwide Adoption of Industry's First Search Engine Built for Life Science Experimentation ...
EDMONTON, ALBERTA: EDMONTON, ALBERTA -- (Marketwired) -- 09/13/16 -- (TSX VENTURE: CZO) ("Ceapro" or the "Company"), a growth-stage biotechnology company focused on the development and commercializ ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 09/13/16 -- (NASDAQ: ATOS) today announced it has received notice from NASDAQ that Atossa has regained compliance with NASDAQ minimum closing bid price listing rule 5 ...
CAMBRIDGE, MA: MLS Capital Fund II and 1955 Capital Co-Led the Round, With Bandgap Ventures and Initial Investor Phoenix Venture Partners Rounding Out the Syndicate ...
